The effect of somatostatin on stress and inflammatory response in critical patients

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001374

Enrollment

Unknown

Registered

2011-05-26

Start date

2010-12-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

critical patients (ie. trauma, patients with inflammatory diseases)

Interventions

control group:not use somatostatin

experimental group:use somatostatin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The first 72 hours onset of stress and inflammatory response

Exclusion criteria

Exclusion criteria: seriously damage of organs

Design outcomes

Primary

Measure	Time frame
clinical index;	—

Secondary

Measure	Time frame
ACTH;IL-1;IL-6;VEGF;	—

Contacts

Public ContactTuanjie ZHU

yephuw@yahoo.com.cn+8615862414916

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026